ZelosDx Overview
- Founded
-
2010

- Status
-
Private
- Employees
-
7

- Latest Deal Type
-
Grant
- Investors
-
13
ZelosDx General Information
Description
Operator of a neurodiagnostic company intended to commercialize blood testing products that help researchers make discoveries for brain health and diseases. The company's services include providing critical data that can be useful in diagnosis, monitoring, and assessing therapeutics response, enabling pharmaceutical companies to use their technology as tools for drug discovery and by researchers conducting studies in brain disease.
Contact Information
Website
www.zelosdx.com
Formerly Known As
MSDx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
- 245 South Plumer Avenue
- Suite 7
- Tucson, AZ 85719
- United States
+1 (520) 000-0000
ZelosDx Timeline
ZelosDx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Grant | 01-Oct-2021 | 00.00 | Completed | Product In Beta Test | ||
9. Grant | 27-Jun-2021 | 00000 | 00.00 | Completed | Product Development | |
8. Later Stage VC | 04-May-2021 | 00000 | 00.00 | 00.00 | Completed | Product Development |
7. Seed Round | 01-Jun-2015 | 00000 | 00.00 | 00.000 | Completed | Product Development |
6. Accelerator/Incubator | 03-Oct-2014 | 00000 | 00.000 | 00.00 | Completed | Product Development |
5. Grant | 01-Jan-2013 | 00000 | 00.00 | 000 | Completed | Product Development |
4. Seed Round | 27-May-2012 | 00.00 | 00.00 | 00.00 | Completed | Product Development |
3. Grant | 01-Jan-2012 | 00000 | 00000 | 00.00 | Completed | Product Development |
2. Early Stage VC | 03-Dec-2010 | $602K | $602K | 000 | Completed | Product Development |
1. Grant | 01-Nov-2010 | $205K | Completed | Product Development |
ZelosDx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A-3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series A-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series A-1 | 1,200,000 | $0.001000 | $0.5 | $0.5 | 1x | $0.5 | 10.41% |
ZelosDx Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a neurodiagnostic company intended to commercialize blood testing products that help researchers make discov
Discovery Tools (Healthcare)
Tucson, AZ
7
As of 2023
00.00
0000000000
00.00
ZelosDx Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
000000000 | Formerly PE-Backed | Billerica, MA | 000 | 00000 | 00000000 | 00000 |
ZelosDx Patents
ZelosDx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220236292-A1 | Detection of debris in recirculating phagocytes | Pending | 09-May-2019 | 000000000000 | |
CA-2929711-A1 | Detection of neurological diseases via measurement of neuromelanin in recirculating phagocytes | Inactive | 05-Nov-2012 | 00000000000 | |
CA-2900634-A1 | Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1 | Active | 10-Feb-2012 | 0000000000 | |
CA-2900634-C | Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1 | Active | 10-Feb-2012 | 0000000000 | |
EP-2812696-B1 | Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1 | Active | 10-Feb-2012 | G01N33/564 |
ZelosDx Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Marie Wesselhoft | Co-Founder, President & Board Member | ||
Betty Weaver | Financial Controller |
ZelosDx Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Conrad Plimpton | ZelosDx | Chairman | 000 0000 |
David McCaleb | ZelosDx | Board Member | 000 0000 |
Marie Wesselhoft | ZelosDx | Co-Founder, President & Board Member | 000 0000 |
Michael Sember | ZelosDx | Vice Chairman | 000 0000 |
ZelosDx Signals
ZelosDx Investors (13)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Science Foundation | Government | 000 0000 | 000000 0 | ||
HOTVentures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Conrad Plimpton | Angel (individual) | Minority | 000 0000 | 000000 0 | |
David McCaleb | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Michael Sember | Angel (individual) | Minority | 000 0000 | 000000 0 |